Analysts and estimates

The following financial analysts monitor the market environment and the performance of Aurubis AG and make investment recommendations in accordance with their analyses and reports on Aurubis shares. The following list is not necessarily exhaustive.

Buy (overweight/outperform/add): The price of the analyzed share is expected to rise over the next 12 months.

Hold (equal-weight/neutral): The price of the analyzed share is expected to remain mostly flat over the next 12 months. 

Sell (underweight/underperform/reduce): The price of the analyzed share is expected to fall over the next 12 months.

Company Analyst Recommendation Target price in €
Baader Bank Christian Obst  Add 110
Bank of America  Jason Fairclough  Underperform  67
Oddo BHF/ Commerzbank Maxime Kogge Outperform 132
Deutsche Bank  Bastian Synagowitz Hold  100
DZ Bank AG Dirk Schlamp Hold 82
Exane BNP Paribas Jatinder Goel Neutral 94,50
Kepler Cheuvreux Rochus Brauneiser Reduce 70
LBBW Jens Münstermann Hold 95
M.M. Warburg Stefan Augustin Buy 110
Morgan Stanley Ioannis Masvoulas Underweight 93
Metzler David Varga Buy 139

Data as of February 7, 2023

Legal disclaimer

Note: The analyst estimates presented are not based on research conducted by Aurubis AG, but on the assessments, reports, recommendations, and analyses of the listed equity research analysts. The presentation of this information as a service for our shareholders does not mean that Aurubis AG adopts, supports, or confirms the analysts' recommendations. None of the data and information provided on this website constitutes an offer to buy, sell, or otherwise trade in securities. In particular, the information does not contain any recommendation for an investment strategy. Aurubis AG accepts no liability whatsoever for the selection, completeness, or correctness of the analysts' assessments presented here. Aurubis AG accepts no liability for damages incurred by third parties as a result of information on this website.